Insider · CIK 0001826766
Christopher Dinsmore
Files at KRON (Kronos Bio, Inc.), THRD (Third Harmonic Bio, Inc.). First filing Dec 13, 2023, latest Jan 5, 2024.
In brief
Christopher Dinsmore files SEC Form 4 as officer at KRON (Kronos Bio, Inc.), and also at THRD (Third Harmonic Bio, Inc.). Since Dec 13, 2023, Christopher Dinsmore has reported 0 open-market buys worth $0 and 2 open-market sells worth $22k, the latest filed on Jan 5, 2024.
A track record needs three past buys with six months of prices behind them; Christopher Dinsmore has 0, so none is measured yet.
The newest scored trade: sold $8,718 of KRON on Jan 4, 2024, filed Jan 5, 2024, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Kronos Bio, Inc. | $8,718 7,366 shares | -3% | - | |
| 23Weak | Kronos Bio, Inc. | $13k 10,032 shares | -4% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | THRD Third Harmonic Bio, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +116,000 | $0.00 | $0 | 116,000 | Jan 17, 2025 |
| Jan 15, 2025 | THRD Third Harmonic Bio, Inc. | AGrant or award Restricted Stock Unitderivative | +14,500 | $0.00 | $0 | 14,500 | Jan 17, 2025 |
| Jan 4, 2024 | KRON Kronos Bio, Inc. | SOpen-market sale Common Stock | -7,366 | $1.18 | $8,718 | 260,969 | Jan 5, 2024 |
| Dec 12, 2023 | KRON Kronos Bio, Inc. | SOpen-market sale Common Stock | -10,032 | $1.31 | $13k | 268,335 | Dec 13, 2023 |
Questions about Christopher Dinsmore
Answered from the filings on this page, as of the latest one.
Is Christopher Dinsmore buying or selling?
Not in the last 12 months. Christopher Dinsmore's latest open-market trade on SEC Form 4 was sold $8,718 of KRON on Jan 4, 2024.
How did Christopher Dinsmore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher Dinsmore has 0.
Where does Christopher Dinsmore file Form 4?
Christopher Dinsmore has filed Form 4 at KRON (Kronos Bio, Inc.) as Chief Scientific Officer; THRD (Third Harmonic Bio, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.